Navigation Links
Verenium Reports Financial Results For The First Quarter Ended March 31, 2013
Date:5/9/2013

ed by significant non-recurring and non-cash items. The Company believes that reporting Adjusted EBITDA on a non-GAAP basis, which excludes the impact of these items, provides a more consistent measure of operating results. It should not be considered, however, in isolation or as a substitute for, or superior to, the financial information presented in the Company's consolidated financial statements.  Further, the Adjusted EBITDA measure shown for the Company may not be comparable to similarly titled measures used by other companies.

The Company reported Adjusted EBITDA loss of $2.5 million for the quarter ended March 31, 2013, compared to Adjusted EBITDA income of $1.4 million for the same quarter in the prior year.  The change in Adjusted EBITDA is primarily attributed to license revenue recorded in 2012 from DSM and Novus International, and increased research and development expenses.

Balance Sheet

The Company ended the quarter with $27.2 million in cash and cash equivalents and $2.5 million in total restricted cash.

"First quarter results are in line with our expectations, reflecting continued steady demand for our Phyzyme® XP phytase product for animal health and nutrition," said James Levine, President & Chief Executive Officer at Verenium.  "Our recent successful corn ethanol plant trial activity demonstrates a strong value proposition for customers in a challenged market, and gives us reason to believe our Grain Processing enzymes will be an important source of revenue growth."

Financial Guidance for 2013Verenium also provided financial guidance for 2013, as follows:

  • Adjusted EBITDA: $(10) – $(12) million
  • Capital Expenditures: $3 - $4 million
  • "The financial guidance we are providing today is based on our expectation of moderate growth in product revenue and product gross profit from our existing commercial products," said Jeff Black, Chief Financial
    '/>"/>

    SOURCE Verenium Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Verenium Reports Financial Results For The Third Quarter And Nine Months Ended September 30, 2012
    2. Verenium To Present At Upcoming Conferences
    3. Verenium To Present At The Jefferies 2012 Global Industrial And Aerospace & Defense Conference
    4. Verenium To Present At The Deutsche Bank 2012 Clean Tech, Utilities & Power Conference
    5. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013
    6. Nektar Therapeutics Reports Financial Results for the First Quarter of 2013
    7. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results
    8. Chindex International, Inc. Reports First Quarter 2013 Financial Results
    9. BioScrip Reports First Quarter 2013 Financial Results
    10. China Biologic Reports Financial Results for the First Quarter of 2013
    11. Nephros Reports First Quarter 2013 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... UPI ), a medical device company that ... voiding dysfunctions, today reported financial results for the fiscal ... revenue for the Company,s Urgent ®  PC Neuromodulation System ... record, as compared to $3.9 million in the third ...
    (Date:1/22/2015)... Jan. 22, 2015  Bio-Techne Corporation (NASDAQ: TECH ... first member of the new Simple Plex platform through ... launch represents the re-branding of the previously acquired CyPlex ... platform is a transformative immunoassay technology which integrates an ...
    (Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and ... the addition of the "Microbiology Testing/Clinical Microbiology ... - Global Forecast to 2019" report to ... a wide array of techniques for the detection ...
    Breaking Medicine Technology:Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 2Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 3
    ... Misonix, Inc. (Nasdaq: MSON ), a ... innovative therapeutic ultrasonic products worldwide for wound debridement, ... and medical applications, announced today that Michael A. ... Richard Zaremba, Chief Financial Officer, are scheduled to ...
    ... Jan. 3, 2011 Clinicians may soon have a new ... (HSV) – one of the most common sexually transmitted infections ... Dickinson and Company) (NYSE: BDX ), announced today ... 510(k) clearance for the first fully automated molecular tests to ...
    Cached Medicine Technology:Misonix to Present at Sidoti & Company 2011 Micro Cap Conference 2New Amplified Molecular Tests Promise to Help Improve Diagnosis and Treatment of Herpes Patients 2
    (Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce ... ever created for kids with cancer. The Chemo Duck App, available ... filled with enjoyable games to help children of all ages living ... helps to keep kids entertained, educated and at ease while waiting ...
    (Date:1/22/2015)... is a seasoned and trusted leader who consistently delivers trendy ... have it lead the wedding dress industry into the future. ... for the global market. , “The CEO of VogueQueen is ... on continuing the goal of operational excellence and giving back ...
    (Date:1/22/2015)... January 23, 2015 Angelweddingdress is a famous ... invites its customers to follow it on Facebook, Twitter, and ... Valentine’s Day gift. Angelweddingdress draws a lottery every week. , ... to Feb. 28, 2015. Click Angelweddingdress homepage for ...
    (Date:1/22/2015)... the premier women’s dress supplier, has recently released its ... of AngelWeddingDress.com to find more details. , Many ... a bridal party. AngelWeddingDress offers a variety of gorgeous ... wedding dresses are specially designed for 2015. , AngelWeddingDress ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 Juvent Sports ... at the 2015 PGA Merchandise Show to bestow a ... incredible female amateur golfer, Arlene McKitrick. The award commemorated ... amateur golf tournament win. She won her first amateur ...
    Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3
    ... Products and Pipeline to Enhance Galderma,s Position in ... 26 ,Galderma Pharma S.A., a global specialty pharmaceutical ... CGPI ) today,announced a definitive agreement pursuant ... will acquire all of the outstanding,shares of CollaGenex ...
    ... published by the European Society of Cardiology1 and the ... in cardiovascular disease across Europe. One fact, nevertheless, ... cause of death in the European Union, killing over ... economy over 192 billion Euros annually. Many of ...
    ... VIEJO, Calif., Feb. 25 The Ensign,Group, ... company of the Ensign(TM) group of,skilled nursing, ... that GE Healthcare Financial Services has expanded,Ensign,s ... it an,additional five years., (Logo: ...
    ... for Patient Safety Legislation Essential to Reduce ... ST. PAUL, Minn., Feb. 25 The ... be addressed with legislation,advanced by the Minnesota ... will champion "Staffing For Patient Safety" legislation,that ...
    ... Blunt (Mo.) issued the following statement today regarding ... Leader John,Boehner (Ohio) and Democratic Leader Steny Hoyer ... path to economic stability:, "This legislation makes ... path to long-term economic stability. Without attention by,2017, ...
    ... First Therapeutic Community,Program in the National Registry of ... 25 The Phoenix Academy,Therapeutic Community (TC) model ... community program for adolescents to be listed,in the ... by United States Department of Health and Human ...
    Cached Medicine News:Health News:Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals 2Health News:Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals 3Health News:Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals 4Health News:Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals 5Health News:Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals 6Health News:The human and economic cost of heart disease in Europe 2Health News:The human and economic cost of heart disease in Europe 3Health News:The Ensign Group Establishes $50 Million Credit Facility with GE Healthcare Financial Services 2Health News:Minnesota Registered Nurses Promote Law to Improve Patient Care and Address Health Care Costs 2Health News:Minnesota Registered Nurses Promote Law to Improve Patient Care and Address Health Care Costs 3Health News:Minnesota Registered Nurses Promote Law to Improve Patient Care and Address Health Care Costs 4Health News:Phoenix Academy's Therapeutic Community Model Is First to be Federally Recognized as Evidence-Based 2
    Catalano curved tying forcep has 6 mm V-grove tying platform. Overall length 100 mm....
    McPherson curved tying forceps is long has curved shafts with tying platform 4 mm, serrated handle and polished finish. Overall length 110 mm....
    McPherson straight tying forceps have straight shafts, tying platforms 4 mm, serrated handle, polished finish, overall length 85 mm....
    Suture tying forceps (S&T) is straight, 13.5 cm long, flat handle, 9 mm wide, tip diameter 0.3 mm with tying platform....
    Medicine Products: